Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

128
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
128
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

36
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
36
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

47
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
47
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

194
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
194
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

41
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
41
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

129
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
129

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The cardiorenometabolic syndrome as a new clinical paradigm in precision medicine].

Archivos de cardiologia de Mexico·2026
Same author

PaCO<sub>2</sub> as a Possible Treatable Trait in Acute Respiratory Failure: A Scoping Review.

Journal of clinical medicine·2026
Same author

PaCO<sub>2</sub>: a treatable trait in acute respiratory failure.

Frontiers in medicine·2026
Same author

Metabolic Kidney Disease: A New Concept in the Interaction Between Obesity, Prediabetes, Diabetes and Liver Dysfunction.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same author

Efficacy and safety of finerenone in diabetic kidney disease: Latin American experience from FINDKDLATAM trial.

World journal of nephrology·2026
Same author

Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026

Related Experiment Video

Updated: Aug 7, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K

Critically Ill Patients with Renal Hyperfiltration: Optimizing Antibiotic Dose.

Jorge Rico-Fontalvo1, José Correa-Guerrero2, María Cristina Martínez-Ávila3

  • 1Colombian Association of Nephrology and Hypertension, Bogota, Colombia.

International Journal of Nephrology
|March 10, 2023
PubMed
Summary

Renal hyperfiltration (RHF) in critically ill patients leads to augmented renal clearance (ARC), increasing drug elimination. This review examines RHF, its risk factors, and optimizing antibiotic dosing to improve patient outcomes.

More Related Videos

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.2K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K

Related Experiment Videos

Last Updated: Aug 7, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.2K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K

Area of Science:

  • Nephrology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Renal hyperfiltration (RHF) and augmented renal clearance (ARC) are common in critically ill patients.
  • This condition increases the elimination of renally cleared medications, including antibiotics.
  • Suboptimal drug exposure due to RHF/ARC can lead to treatment failure and poor patient outcomes.

Purpose of the Study:

  • To review the current evidence on renal hyperfiltration in critically ill patients.
  • To discuss the definition, epidemiology, risk factors, and pathophysiology of RHF.
  • To explore pharmacokinetic variability and strategies for optimizing antibiotic dosing in this population.

Main Methods:

  • Literature review of studies on renal hyperfiltration and augmented renal clearance.
  • Analysis of risk factors, underlying mechanisms, and clinical implications.
  • Examination of antibiotic dosing considerations in critically ill patients with RHF/ARC.

Main Results:

  • RHF and ARC are significant factors influencing drug clearance in critical illness.
  • Multiple risk factors and potential mechanisms contribute to RHF.
  • Optimizing antibiotic dosing is crucial to prevent suboptimal drug exposure.

Conclusions:

  • Renal hyperfiltration is a critical consideration in managing critically ill patients.
  • Understanding RHF/ARC is essential for effective antibiotic therapy.
  • Further research is needed to refine antibiotic dosing strategies for RHF patients.